Bank Of New York Mellon Corp Hoth Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $1.05 $99 - $276	-263 Reduced 0.68%	38,627 $16,000
Q3 2021 Nov 12, 2021	BUY	$1.15 - $1.62 $14,185 - $19,982	12,335 Added 46.45%	38,890 $46,000
Q1 2021 May 13, 2021	BUY	$1.85 - $3.04 $49,126 - $80,727	26,555 New	26,555 $52,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.